The Benefit of Her2-Targeted Therapies on Overall Survival of Patients with Metastatic Her2-Positive Breast Cancer - a Systematic Review
AuthID
P-00G-XCV
P-00G-XCV
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service